210 related articles for article (PubMed ID: 26277616)
21. Oral chronic graft-versus-host disease in Australia: clinical features and challenges in management.
Hull K; Kerridge I; Avery S; McCullough M; Ritchie D; Szer J
Intern Med J; 2015 Jul; 45(7):702-10. PubMed ID: 26134695
[TBL] [Abstract][Full Text] [Related]
22. Measurement of oral chronic GVHD: results from the Chronic GVHD Consortium.
Treister N; Chai X; Kurland B; Pavletic S; Weisdorf D; Pidala J; Palmer J; Martin P; Inamoto Y; Arora M; Flowers M; Jacobsohn D; Jagasia M; Arai S; Lee SJ; Cutler C
Bone Marrow Transplant; 2013 Aug; 48(8):1123-8. PubMed ID: 23353804
[TBL] [Abstract][Full Text] [Related]
23. Genital chronic GVHD in men after hematopoietic stem cell transplantation: a single-center cross-sectional analysis of 155 patients.
Mueller SM; Haeusermann P; Rovó A; Halter JP; Passweg J; Itin P; Tichelli A
Biol Blood Marrow Transplant; 2013 Nov; 19(11):1574-80. PubMed ID: 23962394
[TBL] [Abstract][Full Text] [Related]
24. Frailty in Patients with Chronic Graft-versus-Host Disease.
Rashid N; Arora M; Jurdi NE; Onstad L; Pidala JA; Flowers ME; Lee SJ
Transplant Cell Ther; 2023 Jun; 29(6):367-374. PubMed ID: 36921916
[TBL] [Abstract][Full Text] [Related]
25. Validation of National Institutes of Health global scoring system for chronic graft-versus-host disease (GVHD) according to overall and GVHD-specific survival.
Moon JH; Sohn SK; Lambie A; Ellis L; Hamad N; Uhm J; Gupta V; Lipton JH; Messner HA; Kuruvilla J; Kim D
Biol Blood Marrow Transplant; 2014 Apr; 20(4):556-63. PubMed ID: 24447907
[TBL] [Abstract][Full Text] [Related]
26. Clinical and histopathological features of the oral mucosa in allogeneic haematopoietic stem cell transplantation patients.
Demarosi F; Lodi G; Carrassi A; Moneghini L; Sarina B; Sardella A
Exp Oncol; 2007 Dec; 29(4):304-8. PubMed ID: 18199988
[TBL] [Abstract][Full Text] [Related]
27. Oral Complications of Chronic Graft-Versus-Host Disease.
Fall-Dickson JM; Pavletic SZ; Mays JW; Schubert MM
J Natl Cancer Inst Monogr; 2019 Aug; 2019(53):. PubMed ID: 31425593
[TBL] [Abstract][Full Text] [Related]
28. Incidence and prognostic value of eosinophilia in chronic graft-versus-host disease after nonmyeloablative hematopoietic cell transplantation.
Ahmad I; Labbé AC; Chagnon M; Busque L; Cohen S; Kiss T; Lachance S; Roy DC; Sauvageau G; Roy J
Biol Blood Marrow Transplant; 2011 Nov; 17(11):1673-8. PubMed ID: 21601640
[TBL] [Abstract][Full Text] [Related]
29. Diagnosis and staging of chronic graft-versus-host disease in the clinical practice.
Greinix HT; Loddenkemper C; Pavletic SZ; Holler E; Socié G; Lawitschka A; Halter J; Wolff D
Biol Blood Marrow Transplant; 2011 Feb; 17(2):167-75. PubMed ID: 20691801
[TBL] [Abstract][Full Text] [Related]
30. Diagnosis and treatment of ocular chronic graft-versus-host disease: report from the German-Austrian-Swiss Consensus Conference on Clinical Practice in chronic GVHD.
Dietrich-Ntoukas T; Cursiefen C; Westekemper H; Eberwein P; Reinhard T; Bertz H; Nepp J; Lawitschka A; Heiligenhaus A; Seitz B; Messmer EM; Meyer-ter-Vehn T; Basara N; Greinix H; Datiles MB; Lee SJ; Pavletic SZ; Wolff D
Cornea; 2012 Mar; 31(3):299-310. PubMed ID: 22157574
[TBL] [Abstract][Full Text] [Related]
31. Photobiomodulation therapy in the management of chronic oral graft-versus-host disease.
Epstein JB; Raber-Durlacher JE; Lill M; Linhares YP; Chang J; Barasch A; Slief RI; Geuke M; Zecha JA; Milstein DM; Tzachanis D
Support Care Cancer; 2017 Feb; 25(2):357-364. PubMed ID: 27655559
[TBL] [Abstract][Full Text] [Related]
32. Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study.
Fraser CJ; Bhatia S; Ness K; Carter A; Francisco L; Arora M; Parker P; Forman S; Weisdorf D; Gurney JG; Baker KS
Blood; 2006 Oct; 108(8):2867-73. PubMed ID: 16788100
[TBL] [Abstract][Full Text] [Related]
33. Long-Term Morbidity and Mortality in Children with Chronic Graft-versus-Host Disease Classified by National Institutes of Health Consensus Criteria after Allogeneic Hematopoietic Stem Cell Transplantation.
Inagaki J; Moritake H; Nishikawa T; Hyakuna N; Okada M; Suenobu S; Nagai K; Honda Y; Shimomura M; Fukano R; Noguchi M; Kurauchi K; Tanioka S; Okamura J
Biol Blood Marrow Transplant; 2015 Nov; 21(11):1973-80. PubMed ID: 26234723
[TBL] [Abstract][Full Text] [Related]
34. Risk assessment and outcome of chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell transplantation in pediatric patients.
Diaz MA; Vicent MG; Gonzalez ME; Verdeguer A; de la Rubia J; Bargay J; de Arriba F; Diez JL; Caballero D; Madero L; Brunet S;
Bone Marrow Transplant; 2004 Sep; 34(5):433-8. PubMed ID: 15273704
[TBL] [Abstract][Full Text] [Related]
35. Personality influences quality-of-life assessments in adult patients after allogeneic hematopoietic SCT: results from a joint evaluation of the prospective German Multicenter Validation Trial and the Fred Hutchinson Cancer Research Center.
Herzberg PY; Lee SJ; Heussner P; Mumm FH; Hilgendorf I; von Harsdorf S; Hemmati P; Rieger K; Greinix HT; Freund M; Holler E; Wolff D
Bone Marrow Transplant; 2013 Jan; 48(1):129-34. PubMed ID: 22609882
[TBL] [Abstract][Full Text] [Related]
36. Oral chronic graft-vs.-host disease characterization using the NIH scale.
Fassil H; Bassim CW; Mays J; Edwards D; Baird K; Steinberg SM; Williams KM; Cowen EW; Mitchell SA; Hakim FT; Taylor T; Avila D; Zhang D; Grkovic L; Datiles M; Gress RE; Pavletic SZ
J Dent Res; 2012 Jul; 91(7 Suppl):45S-51S. PubMed ID: 22699667
[TBL] [Abstract][Full Text] [Related]
37. Chronic graft-versus-host disease after reduced-intensity stem cell transplantation versus conventional hematopoietic stem cell transplantation.
Busca A; Rendine S; Locatelli F; Sizzano F; Dall'omo AM; Rossi G; Falda M
Hematology; 2005 Feb; 10(1):1-10. PubMed ID: 16019440
[TBL] [Abstract][Full Text] [Related]
38. The impact of morphological and immunohistological changes in minor salivary glands on the health of the oral cavity in HSCT patients.
Soares TC; Correa ME; Cintra GF; Miranda EC; Cintra ML
Bone Marrow Transplant; 2013 Nov; 48(12):1525-9. PubMed ID: 23892328
[TBL] [Abstract][Full Text] [Related]
39. Impact of GvHD on quality of life in long-term survivors of haematopoietic transplantation.
Pallua S; Giesinger J; Oberguggenberger A; Kemmler G; Nachbaur D; Clausen J; Kopp M; Sperner-Unterweger B; Holzner B
Bone Marrow Transplant; 2010 Oct; 45(10):1534-9. PubMed ID: 20228854
[TBL] [Abstract][Full Text] [Related]
40. Corticosteroid-Free Primary Treatment of Chronic Extensive Graft-versus-Host Disease Incorporating Rituximab.
Solomon SR; Sizemore CA; Ridgeway M; Zhang X; Smith J; Brown S; Holland HK; Morris LE; Bashey A
Biol Blood Marrow Transplant; 2015 Sep; 21(9):1576-82. PubMed ID: 25985915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
